Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

MDLN

Medline Inc.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 2046386Held by 11 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$28.43B
Net Income FY2025
$1.16B
EPS (Basic, as reported)
$-0.01
Net Margin FY2025
4.1%
ROE FY2025
10.8%
Total Equity
$10.74B
Shares Out
—
Business description

Medline Inc. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 23,231 → 28,432 +10.6% CAGR
Fiscal yearFY2023FY2024FY2025
Revenue23,23125,50728,432
Cost of revenue(17,346)(18,531)(20,914)
Gross profit5,8856,9767,518
Research & development(60)(67)(80)
Selling, general & administrative(3,867)(4,108)(4,524)
Total operating expenses(4,635)(4,830)(5,306)
Operating income1,2502,1462,212
Interest expense(1,213)(1,144)(945)
Interest & investment income237280133
Other income (expense), net(986)(900)(964)
Pre-tax income2641,2461,248
Income tax expense(30)(46)(91)
Net income2341,1631,159
EPS — basic——($0.01)
EPS — diluted——($0.01)
Shares outstanding — basic (M)——810
Shares outstanding — diluted (M)——810

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.